Valuation: SenzaGen AB

Market Cap 167M 17.62M 15.09M 14.15M 12.91M 24.38M 1.69B 24.64M 64.94M 846M 66.12M 64.68M 2.82B P/E 2024
-10.5x
P/E 2025 -15.5x
Enterprise Value 159M 16.79M 14.38M 13.48M 12.3M 23.23M 1.61B 23.47M 61.87M 806M 62.99M 61.61M 2.69B EV / Sales 2024
2.87x
EV / Sales 2025 2.96x
Free-Float
75.1%
Yield 2024 *
-
Yield 2025 -
1 day-0.39%
1 week-3.02%
Current month-1.91%
1 month-3.75%
3 months-3.38%
6 months-11.07%
Current year-15.46%
1 week 4.98
Extreme 4.98
5.32
1 month 4.98
Extreme 4.98
5.7
Current year 4.6
Extreme 4.6
6.4
1 year 4.6
Extreme 4.6
6.84
3 years 3.86
Extreme 3.86
9.8
5 years 3.86
Extreme 3.86
17
10 years 3.86
Extreme 3.86
74
Manager TitleAgeSince
Chief Executive Officer 52 19/08/2021
Director of Finance/CFO 65 01/11/2016
Chief Operating Officer 44 01/01/2014
Director TitleAgeSince
Chairman 78 01/01/2015
Director/Board Member 61 17/06/2019
Director/Board Member 76 01/01/2015
Date Insider Type Main position Quantity % Market Cap.
01/09/20 Buy

Chief Executive Officer

25,000 0.1171%
01/09/20 Buy

Chief Executive Officer

480 0.0022%
Change 5-day change 1-year change 3-year change Capi.($)
-0.39%-3.02%-14.33%-43.02% 17.71M
-1.69%+3.27%+96.54%+293.08% 4.15B
-2.77%+15.47%+199.63%+27.73% 3.76B
-1.99%+0.53%+33.77%+58.04% 3.4B
-2.28%+4.81%+266.23%+441.62% 2.51B
-0.71%+3.10%-21.61%-20.34% 2.41B
-0.88%+16.87%+27.81% - 1.48B
-2.43%+47.89%+244.08%-20.25% 1.29B
+5.41%0.00%+22.94%+49.53% 1B
-0.67%-3.47%-36.72%+1.04% 552M
Average -0.84%+11.11%+81.83%+87.49% 2.06B
Weighted average by Cap. -1.51%+11.29%+108.90%+136.32%

Financials

2024 2025
Net sales 57.7M 6.08M 5.21M 4.88M 4.46M 8.42M 582M 8.51M 22.42M 292M 22.83M 22.33M 975M 57.97M 6.11M 5.24M 4.91M 4.48M 8.46M 585M 8.55M 22.53M 293M 22.94M 22.44M 980M
Net income -17.85M -1.88M -1.61M -1.51M -1.38M -2.6M -180M -2.63M -6.94M -90.36M -7.06M -6.91M -302M -11.59M -1.22M -1.05M -981K -895K -1.69M -117M -1.71M -4.5M -58.66M -4.58M -4.48M -196M
Net Debt -37.83M -3.99M -3.42M -3.2M -2.92M -5.52M -382M -5.58M -14.7M -191M -14.97M -14.64M -639M -7.91M -834K -715K -670K -611K -1.15M -79.83M -1.17M -3.08M -40.05M -3.13M -3.06M -134M
Logo SenzaGen AB
SenzaGen AB is a Sweden-based company, which specializes in immunology, technology and genomics. The Company markets, sells and performs the in vitro Genomic Allergen Rapid Detection (GARD) sensitization test through its own laboratory and through licensed Contract Research Organization (CROs). SenzaGen AB makes it possible to replace animal experiments with in vitro genetic testing to determine the allergenicity of the chemicals people come in contact with in their daily lives, such as for example in cosmetics, pharmaceuticals, food products and dyes. The Company sells the tests in Sweden and the United States, and also sells through partners in several other countries. SenzaGen AB has a subsidiary in San Francisco, the United States.
Employees
33
Date Price Change Volume
24/08/26 SEK 5.140 -0.39% 9,758
21/08/26 SEK 5.160 -0.39% 22,869
20/08/26 SEK 5.180 -1.52% 27,033
19/08/26 SEK 5.260 +0.38% 11,933
18/08/26 SEK 5.240 +0.38% 4,987

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SENZA Stock